Group 1 - The stock price of Kangchen Pharmaceutical closed at 50.65 yuan on August 26, 2025, down by 2.30 yuan, representing a decline of 4.34% from the previous trading day [1] - The trading volume on that day was 240 million yuan, with a turnover rate of 2.97% [1] - Kangchen Pharmaceutical's main business includes the research, production, and sales of innovative drugs, covering areas such as anti-tumor and hematological diseases [1] Group 2 - The company is part of concept sectors including biopharmaceuticals, innovative drugs, and specialized new products [1] - On August 27, 2025, Kangchen Pharmaceutical will hold its second extraordinary general meeting to review proposals for changes in registered capital and amendments to the company’s articles of association [1] - On August 26, 2025, there was a net outflow of 30.71 million yuan in main funds, with a cumulative net outflow of 137 million yuan over the past five days [1]
康辰药业股价下跌4.34% 临时股东大会明日召开